International Rectifier Corporation (NYSE:IRF) released that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) by means of respect to the Company's acquisition by German chip maker Infineon Technologies AG (IFNNY), expired at 11:59 p.m., New York City time, on Friday, October 24, 2014. International Rectifier Corporation (NYSE:IRF) stock has highest price of $39.725 in last session, beginning with a price of $39.60 and reported a gain of 0.30% to the closed at $39.60 with a day range of $39.55-$39.725. The stock is going forward its 52-week low with 73.15% and moving down from its 52 week high price with -0.35%.Pharmaceutical giant, Pfizer Inc. (NYSE:PFE) released that it has informed Pain Therapeutics Inc. (PTIE) of its verdict to discontinue their agreement to develop and commercialize Remoxy, or oxycodone Extended-Release Capsules CII, an investigational expanded-release oral formulation of oxycodone for patients with moderate-to-severe chronic pain. Shares of Pfizer Inc. (NYSE:PFE) traded at $29.03 by moving down -0.27% with price volatility of 1.49% for a week and 1.63% for a month. Its beta stands at 0.70 times.Exact Sciences Corporation (NASDAQ:EXAS) released that a net loss for the Q3 of $32.1M or $0.39 a share, as compared to a net loss of $11.2M or $0.16 per share for the year-ago quarter. Exact Sciences Corporation (NASDAQ:EXAS) stock hit highest price at $23.81, beginning with a price of $23.00 and reported an advance of 0.21% to the closed at $23.61 with a day range of $22.06-$23.81. The total market capitalization remained 1.958 Billion, total volume of 2.41 Million shares held in the session was surprisingly higher than its average volume of 2362.75 shares.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
